Home
About Us
Our Mission
Management
Board of Directors
Science Advisors
Science & Pipeline
Overview
Neuroplasticity
DMX-1001
Alcohol use disorder
Publications
Investors & Media
Media releases
News beats
For Investors
Media contact
Contact DemeRx
DemeRx Announces Successful Completion of Multiple Ascending Dose Clinical Trial of DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)
changes
Press Release
6 Jan at 11:42 am
View Article
Previous Post
In Waves and War: Healing Trauma Through the Science of Neuroplasticity
Menu
